npb-01
Showing 1 - 7 of 7
Guillain-Barré Syndrome Trial in Osaka (NPB-01)
Completed
- Guillain-Barré Syndrome
- NPB-01
-
Osaka, JapanNihon Pharmaceutical Co., Ltd
Apr 11, 2017
Neuromyelitis Optica Spectrum Disorder Trial in Osaka, (NPB-01)
Completed
- Neuromyelitis Optica Spectrum Disorder
- NPB-01
-
Osaka,, JapanJapan
Apr 11, 2017
Multifocal Motor Neuropathy Trial in Osaka (NPB-01)
Completed
- Multifocal Motor Neuropathy
- NPB-01
-
Osaka, JapanNihon Pharmaceutical Co., Ltd
Jan 17, 2016
Chronic Inflammatory Demyelinating Polyneuropathy Trial in Osaka (NPB-01)
Completed
- Chronic Inflammatory Demyelinating Polyneuropathy
- NPB-01
-
Osaka, JapanNihon Pharmaceutical Co., Ltd
Jan 17, 2016
Bullous Pemphigoid Trial in Osaka (NPB-01, Placebo)
Completed
- Bullous Pemphigoid
- NPB-01
- Placebo
-
Osaka, Japan(unnamed)
Oct 15, 2013
Bullous Pemphigoid Trial in Osaka (NPB-01, Placebo)
Completed
- Bullous Pemphigoid
- NPB-01
- Placebo
-
Osaka, Japan(unnamed)
Oct 21, 2010